Clinical trial
A Different Level of Single-dose and Multiple-dose Study to Evaluate the Pharmacokinetics of Bilastine in a Chinese Population
NCT03633760 is registered in ClinicalTrials.gov with A.Menarini Asia-Pacific Holdings Pte Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Different Level of Single-dose and Multiple-dose Study to Evaluate the Pharmacokinetics of Bilastine in a Chinese Population
- Lead sponsor
- A.Menarini Asia-Pacific Holdings Pte Ltd
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- August 28, 2018
- Completion date
- July 31, 2019
- Enrollment
- 24 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pharmacokinetics